Capabilities

Industries / Issues

Coronavirus

2019 Novel Coronavirus (COVID-19) continues its rapid proliferation across the globe with complex and widening implications.  While there are still many unknowns, King & Spalding has been mobilized to assist our clients since the initial reports of the outbreak, helping them to address early stage responses across their operations, while considering the long-term commercial and legal impact.

King & Spalding’s Crisis Practice, which includes lawyers from our Special Matters and Government Investigations, Employment, Corporate Governance, Insurance Coverage and Recovery, Litigation, International Arbitration, Government Advocacy and Public Policy, Leverage Finance, Restructuring, Trade and Data, Privacy and Security teams, brings experience and judgment to help the c-suite, legal team and the Board address mounting business and legal issues.  Our clients benefit from the perspective of our leading Healthcare and Life Sciences team, which is in regular contact with the CDC and other regulatory bodies that are coordinating the U.S. government’s response. We are also able to leverage relationships with premier global duty of care and crisis communications advisors to help our clients stay in front of today’s unprecedented and rapidly unfolding developments.

COVID-19 Executive Orders

Survey of State and Municipal Shelter-in-Place / Stay-at-Home Orders

View Orders View All

COVID-19 Financial Regulatory Roundup

In the wake of the coronavirus pandemic, regulatory agencies are issuing press releases and regulatory guidance affecting financial services firms. Read more about the summaries and links to guidance issued by the US, UK, and European financial regulators concerning COVID-19.

Read More View All

A Survey of Restrictions on Eviction and Foreclosure Remedies

A survey of residential and commercial restrictions on eviction or other contractual remedies as well as foreclosures

Read More View All

COVID-19 Public Company Disclosure Insights

A live tracker of COVID-19-related SEC filings and disclosure issues

Read More View All